bkibler@altoonamirror.com
A significant percentage of people with certain blood-related cancers don’t develop COVID-19 antibodies from vaccinations, leaving them potentially vulnerable to COVID-19 after they get their shots, according to findings by UPMC that were discussed in a virtual news conference Friday.
Tests done on 67 fully vacÂÂÂÂÂÂÂcinated people with “hematologic malignancies” which include non-solid cancers like leukemia, myeloma and lymphoma showed 46% didn’t produce COVID-19 antibodies, according to Ghady Haidar, transplant infectious diseases physician.
Moreover, of the patients among them with chronic lymphocytic leukemia, 77% failed to produce the antibodies, Haider said.
That doesn’t necessarily mean that the vaccinations won’t help those cancer patients, because the immune system is complex and there are many other elements besides antibodies that can fight off disease, but it does mean that patients with hematologic mali
Certain Cancer Patients at Risk of COVID-19 Vaccine Failure miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.